DIL
SRPT icon

Deeter Investments LLP’s Sarepta Therapeutics SRPT Stock Holding History

Deeter Investments LLP’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.63M Buy
+75,567
New +$1.59M 0.35% 46

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deeter Investments LLP's SRPT Position: Q4 2025 in Review

Deeter Investments LLP opened a new position in Sarepta Therapeutics (SRPT) in Q4 2025: 75,567 shares worth $1.63M. The stake represents 0.35% of the portfolio and ranks #46 among its holdings.

347 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

  • Deeter Investments LLP held 75,567 shares of Sarepta Therapeutics worth $1.63M as of Q4 2025.
  • Sarepta Therapeutics was a new Deeter Investments LLP position in Q4 2025.
  • Sarepta Therapeutics made up 0.35% of Deeter Investments LLP's portfolio in Q4 2025, its #46 holding.
  • 347 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on Deeter Investments LLP's 13F filing for Q4 2025, filed 28 Aug 2026.